Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Income Tax Expense

$0.00

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Income Tax Expense

Latest reported$0.00period endingJun 30, 2026

Latest reported$0.00period endingJun 30, 2026

LCTX Quarterly Income Tax ($100.00K → $0.00)

Quarterly income tax expense

High-resolution chart · PNG

LCTX income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Income Tax Expense — Quarterly (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	-5,402
Mar 31, 2001	-6,455
Dec 31, 2000	10,027
Sep 30, 2000	-60,733
Jun 30, 2000	-49,098
Mar 31, 2000	-65,450
Dec 31, 1999	20,173
Sep 30, 1999	2,300,000
Jun 30, 1999	-100,000
Mar 31, 1999	800,000
Sep 30, 1998	0
Jun 30, 1998	100,000
Mar 31, 1998	0
Dec 31, 1997	-200,000
Sep 30, 1997	0
Jun 30, 1997	-200,000
Mar 31, 1997	500,000
Dec 31, 1996	100,000
Sep 30, 1996	100,000
Jun 30, 1996	-1,600,000
Mar 31, 1996	700,000
Dec 31, 1995	700,000
Sep 30, 1995	100,000
Jun 30, 1995	-100,000
Mar 31, 1995	100,000
Dec 31, 1994	100,000
Sep 30, 1994	100,000
Jun 30, 1994	-200,000
Mar 31, 1994	100,000
Dec 31, 1993	100,000
Sep 30, 1993	300,000
Jun 30, 1993	-100,000
Mar 31, 1993	200,000
Dec 31, 1992	300,000
Sep 30, 1992	100,000
Jun 30, 1992	200,000
Mar 31, 1992	100,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.